Organigram Global Inc (OGI) Gross Profit Margin starting from the fourth quarter 2025 to fourth quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Organigram Global Inc   (NASDAQ: OGI)


Organigram Global Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OGI Gross Profit Margin (Sep 30 2025)
Q4 		0
Q3 		0
Q2 		0
Q1 		(Sep 30 2024)
Q4
Y / Y Revenue Change 62.15 %
Seq. Revenue Change -
Revenue In Millions $198.53
Gross Profit Margin 34.81 %
Gross Profit Margin Total Ranking # 2364
Gross Profit In Millions $69.11
Y / Y Gross Profit Change 89.83 %
Seq. Gross Profit Change -


Commenting fourth quarter 2025 Gross Profit Margin



Observing fourth quarter 2025 results within Major Pharmaceutical Preparations industry 132 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 2364.
Learn about Gross Margin
OGI's Gross Profit Margin fourth quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 133
Healthcare Sector # 380
Overall # 2343

Gross Profit Margin Statistics
High Average Low
34.81 % 28.73 % 21.65 %
(Sep 30 2025)   (Sep 30 2023)


OGI Gross Income Trends • More of OGI's Profitabilty Ratios • OGI Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
OGI's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
OGI's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for OGI's Competitors
Gross Profit Margin Profit Margin for Organigram Global Inc 's Suppliers
Gross Profit Margin Profit Margin for OGI's Customers

You may also want to know
OGI's Annual Growth Rates OGI's Profitability Ratios OGI's Asset Turnover Ratio OGI's Dividend Growth
OGI's Roe OGI's Valuation Ratios OGI's Financial Strength Ratios OGI's Gross Profit Growth
OGI's Roa OGI's Inventory Turnover Ratio OGI's Growth Rates OGI's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2025, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2025 MRQ Gross ProfitSep 30 2025 MRQ Revenue
Zevra Therapeutics Inc   95.25 %$ 24.825  Millions$ 26.063  Millions
Karyopharm Therapeutics Inc   95.20 %$ 41.931  Millions$ 44.044  Millions
Vanda Pharmaceuticals Inc   94.75 %$ 53.304  Millions$ 56.258  Millions
Avadel Pharmaceuticals Plc  94.69 %$ 73.351  Millions$ 77.467  Millions
Gyre Therapeutics Inc   94.67 %$ 28.936  Millions$ 30.564  Millions
Kyntra Bio Inc   94.61 %$ 1.018  Millions$ 1.076  Millions
Bridgebio Pharma Inc   94.56 %$ 114.137  Millions$ 120.700  Millions
Rigel Pharmaceuticals Inc  93.16 %$ 64.709  Millions$ 69.462  Millions
Axsome Therapeutics Inc   93.03 %$ 159.080  Millions$ 170.992  Millions
Ligand Pharmaceuticals Incorporated  92.99 %$ 107.364  Millions$ 115.461  Millions
Regeneron Pharmaceuticals Inc   92.52 %$ 3,473.300  Millions$ 3,754.300  Millions
Acadia Pharmaceuticals Inc   92.23 %$ 256.986  Millions$ 278.633  Millions
Arcutis Biotherapeutics Inc   91.25 %$ 90.534  Millions$ 99.219  Millions
Longeveron Inc   91.24 %$ 0.125  Millions$ 0.137  Millions
Kalvista Pharmaceuticals Inc   91.00 %$ 12.460  Millions$ 13.692  Millions
Supernus Pharmaceuticals inc   90.13 %$ 173.138  Millions$ 192.103  Millions
Rhythm Pharmaceuticals Inc   89.28 %$ 45.799  Millions$ 51.298  Millions
Cormedix Inc   89.26 %$ 93.081  Millions$ 104.275  Millions
Uniqure N v   89.25 %$ 3.303  Millions$ 3.701  Millions
Urogen Pharma Ltd   88.97 %$ 24.204  Millions$ 27.204  Millions
Aurinia Pharmaceuticals Inc   88.87 %$ 65.291  Millions$ 73.468  Millions
Kiniksa Pharmaceuticals International Plc  88.80 %$ 160.598  Millions$ 180.855  Millions
Bioxcel Therapeutics Inc   88.78 %$ 0.087  Millions$ 0.098  Millions
Amicus Therapeutics inc   88.73 %$ 149.594  Millions$ 168.594  Millions
Blue Water Vaccines Inc  88.55 %$ 0.269  Millions$ 0.304  Millions
Cumberland Pharmaceuticals Inc   88.08 %$ 7.304  Millions$ 8.292  Millions
Ocular Therapeutix Inc   87.80 %$ 12.770  Millions$ 14.544  Millions
Phathom Pharmaceuticals Inc   87.50 %$ 43.314  Millions$ 49.504  Millions
United Therapeutics Corporation  87.38 %$ 698.600  Millions$ 799.500  Millions
Ovid Therapeutics Inc   87.12 %$ 0.115  Millions$ 0.132  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.